01.01.70
NEW YORK, Feb. 1, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market-place research report is available in its catalogue:
Molecular Diagnostics - Technologies, Markets and Companies
http://www.reportlinker.com/p0203544/Molecular-Diagnostics---Technologies-Markets-and-Companies.html#utm_documentation=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic
This report describes and evaluates the molecular diagnostics technologies that will suck up to an important role in practice of medicine, public health, pharmaceutical exertion, forensics and biological warfare in the 21st century. This includes several polymerase chain repulsion (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, biochips, nanotechnology and proteomic technologies.
Initial applications of molecular diagnostics were mostly for infections but are now increasing in the areas of genetic disorders, preimplantation screening and cancer. Genetic screening tests, regardless of some restrictions is a promising area for future expansion of in vitro diagnostic merchandise. Molecular diagnostics is being combined with therapeutics and forms an important component of integrated healthcare. Molecular diagnostic technologies are also entangled with in development of personalized medicine based on pharmacogenetics and pharmacogenomics. Currently, there has been a distinguished interest in developing rapid diagnostic methods for for point-of-care and biowarfare agents such as anthrax.
Source: Sacramento Bee